시장조사 보고서 : 세계의 종양 세포 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Tumour-cell Vaccine Market Growth 2021-2026
	■ 상품코드 : LPI-2201K02666 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 91 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료장치

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 종양 세포 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (Mvax, OncoVAX, BiovaxID, 기타)와 용도별 시장규모 (소아, 성인) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 종양 세포 백신 시장 점유율
- 지역별 종양 세포 백신 시장규모
- 주요지역의 종류별 시장규모 (Mvax, OncoVAX, BiovaxID, 기타)
- 주요지역의 용도별 시장규모 (소아, 성인)
- 미주의 종양 세포 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 종양 세포 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 종양 세포 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 종양 세포 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 종양 세포 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
AVAX Technologies, Vaccinogen, Biovest, Aduro BioTech, Regeneus
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Tumour-cell Vaccine will have significant change from previous year. By the most conservative estimates of global Tumour-cell Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Tumour-cell Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumour-cell Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
MVax
OncoVAX
BiovaxID
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Pediatrics
Adults

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AVAX Technologies
Vaccinogen
Biovest
Aduro BioTech
Regeneus

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumour-cell Vaccine Consumption 2016-2026
2.1.2 Tumour-cell Vaccine Consumption CAGR by Region
2.2 Tumour-cell Vaccine Segment by Type
2.2.1 MVax
2.2.2 OncoVAX
2.2.3 BiovaxID
2.2.4 Others
2.3 Tumour-cell Vaccine Sales by Type
2.3.1 Global Tumour-cell Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Tumour-cell Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Tumour-cell Vaccine Sale Price by Type (2016-2021)
2.4 Tumour-cell Vaccine Segment by Application
2.4.1 Pediatrics
2.4.2 Adults
2.5 Tumour-cell Vaccine Sales by Application
2.5.1 Global Tumour-cell Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Tumour-cell Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Tumour-cell Vaccine Sale Price by Application (2016-2021)

3 Global Tumour-cell Vaccine by Company
3.1 Global Tumour-cell Vaccine Sales Market Share by Company
3.1.1 Global Tumour-cell Vaccine Sales by Company (2019-2021)
3.1.2 Global Tumour-cell Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Tumour-cell Vaccine Revenue Market Share by Company
3.2.1 Global Tumour-cell Vaccine Revenue by Company (2019-2021)
3.2.2 Global Tumour-cell Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Tumour-cell Vaccine Sale Price by Company
3.4 Global Manufacturers Tumour-cell Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumour-cell Vaccine Product Location Distribution
3.4.2 Players Tumour-cell Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Tumour-cell Vaccine by Region
4.1 Global Tumour-cell Vaccine by Region
4.1.1 Global Tumour-cell Vaccine Sales by Region
4.1.2 Global Tumour-cell Vaccine Revenue by Region
4.2 Americas Tumour-cell Vaccine Sales Growth
4.3 APAC Tumour-cell Vaccine Sales Growth
4.4 Europe Tumour-cell Vaccine Sales Growth
4.5 Middle East & Africa Tumour-cell Vaccine Sales Growth

5 Americas
5.1 Americas Tumour-cell Vaccine Sales by Country
5.1.1 Americas Tumour-cell Vaccine Sales by Country (2016-2021)
5.1.2 Americas Tumour-cell Vaccine Revenue by Country (2016-2021)
5.2 Americas Tumour-cell Vaccine Sales by Type
5.3 Americas Tumour-cell Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Tumour-cell Vaccine Sales by Region
6.1.1 APAC Tumour-cell Vaccine Sales by Region (2016-2021)
6.1.2 APAC Tumour-cell Vaccine Revenue by Region (2016-2021)
6.2 APAC Tumour-cell Vaccine Sales by Type
6.3 APAC Tumour-cell Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Tumour-cell Vaccine by Country
7.1.1 Europe Tumour-cell Vaccine Sales by Country (2016-2021)
7.1.2 Europe Tumour-cell Vaccine Revenue by Country (2016-2021)
7.2 Europe Tumour-cell Vaccine Sales by Type
7.3 Europe Tumour-cell Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Tumour-cell Vaccine by Country
8.1.1 Middle East & Africa Tumour-cell Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Tumour-cell Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Tumour-cell Vaccine Sales by Type
8.3 Middle East & Africa Tumour-cell Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Tumour-cell Vaccine Distributors
10.3 Tumour-cell Vaccine Customer

11 Global Tumour-cell Vaccine Market Forecast
11.1 Global Tumour-cell Vaccine Forecast by Region
11.1.1 Global Tumour-cell Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Tumour-cell Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Tumour-cell Vaccine Forecast by Type
11.7 Global Tumour-cell Vaccine Forecast by Application

12 Key Players Analysis
12.1 AVAX Technologies
12.1.1 AVAX Technologies Company Information
12.1.2 AVAX Technologies Tumour-cell Vaccine Product Offered
12.1.3 AVAX Technologies Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AVAX Technologies Main Business Overview
12.1.5 AVAX Technologies Latest Developments
12.2 Vaccinogen
12.2.1 Vaccinogen Company Information
12.2.2 Vaccinogen Tumour-cell Vaccine Product Offered
12.2.3 Vaccinogen Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Vaccinogen Main Business Overview
12.2.5 Vaccinogen Latest Developments
12.3 Biovest
12.3.1 Biovest Company Information
12.3.2 Biovest Tumour-cell Vaccine Product Offered
12.3.3 Biovest Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Biovest Main Business Overview
12.3.5 Biovest Latest Developments
12.4 Aduro BioTech
12.4.1 Aduro BioTech Company Information
12.4.2 Aduro BioTech Tumour-cell Vaccine Product Offered
12.4.3 Aduro BioTech Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Aduro BioTech Main Business Overview
12.4.5 Aduro BioTech Latest Developments
12.5 Regeneus
12.5.1 Regeneus Company Information
12.5.2 Regeneus Tumour-cell Vaccine Product Offered
12.5.3 Regeneus Tumour-cell Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Regeneus Main Business Overview
12.5.5 Regeneus Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Tumour-cell Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of MVax
Table 3. Major Players of OncoVAX
Table 4. Major Players of BiovaxID
Table 5. Major Players of Others
Table 6. Global Tumour-cell Vaccine Sales by Type (2016-2021) & (K Units)
Table 7. Global Tumour-cell Vaccine Sales Market Share by Type (2016-2021)
Table 8. Global Tumour-cell Vaccine Revenue by Type (2016-2021) & ($ million)
Table 9. Global Tumour-cell Vaccine Revenue Market Share by Type (2016-2021)
Table 10. Global Tumour-cell Vaccine Sale Price by Type (2016-2021)
Table 11. Global Tumour-cell Vaccine Sales by Application (2016-2021) & (K Units)
Table 12. Global Tumour-cell Vaccine Sales Market Share by Application (2016-2021)
Table 13. Global Tumour-cell Vaccine Value by Application (2016-2021)
Table 14. Global Tumour-cell Vaccine Revenue Market Share by Application (2016-2021)
Table 15. Global Tumour-cell Vaccine Sale Price by Application (2016-2021)
Table 16. Global Tumour-cell Vaccine Sales by Company (2019-2021) & (K Units)
Table 17. Global Tumour-cell Vaccine Sales Market Share by Company (2019-2021)
Table 18. Global Tumour-cell Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Tumour-cell Vaccine Revenue Market Share by Company (2019-2021)
Table 20. Global Tumour-cell Vaccine Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Tumour-cell Vaccine Producing Area Distribution and Sales Area
Table 22. Players Tumour-cell Vaccine Products Offered
Table 23. Tumour-cell Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tumour-cell Vaccine Sales by Region (2016-2021) (K Units)
Table 27. Global Tumour-cell Vaccine Sales Market Share by Region (2016-2021)
Table 28. Global Tumour-cell Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Tumour-cell Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Americas Tumour-cell Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Americas Tumour-cell Vaccine Sales Market Share by Country (2016-2021)
Table 32. Americas Tumour-cell Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Tumour-cell Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Americas Tumour-cell Vaccine Sales by Type (2016-2021) & (K Units)
Table 35. Americas Tumour-cell Vaccine Sales Market Share by Type (2016-2021)
Table 36. Americas Tumour-cell Vaccine Sales by Application (2016-2021) & (K Units)
Table 37. Americas Tumour-cell Vaccine Sales Market Share by Application (2016-2021)
Table 38. APAC Tumour-cell Vaccine Sales by Region (2016-2021) & (K Units)
Table 39. APAC Tumour-cell Vaccine Sales Market Share by Region (2016-2021)
Table 40. APAC Tumour-cell Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Tumour-cell Vaccine Revenue Market Share by Region (2016-2021)
Table 42. APAC Tumour-cell Vaccine Sales by Type (2016-2021) & (K Units)
Table 43. APAC Tumour-cell Vaccine Sales Market Share by Type (2016-2021)
Table 44. APAC Tumour-cell Vaccine Sales by Application (2016-2021) & (K Units)
Table 45. APAC Tumour-cell Vaccine Sales Market Share by Application (2016-2021)
Table 46. Europe Tumour-cell Vaccine Sales by Country (2016-2021) & (K Units)
Table 47. Europe Tumour-cell Vaccine Sales Market Share by Country (2016-2021)
Table 48. Europe Tumour-cell Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Tumour-cell Vaccine Revenue Market Share by Country (2016-2021)
Table 50. Europe Tumour-cell Vaccine Sales by Type (2016-2021) & (K Units)
Table 51. Europe Tumour-cell Vaccine Sales Market Share by Type (2016-2021)
Table 52. Europe Tumour-cell Vaccine Sales by Application (2016-2021) & (K Units)
Table 53. Europe Tumour-cell Vaccine Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Tumour-cell Vaccine Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Tumour-cell Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Tumour-cell Vaccine Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Tumour-cell Vaccine Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Tumour-cell Vaccine Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Tumour-cell Vaccine
Table 63. Key Application and Potential Industries of Tumour-cell Vaccine
Table 64. Key Challenges of Tumour-cell Vaccine
Table 65. Key Trends of Tumour-cell Vaccine
Table 66. Tumour-cell Vaccine Distributors List
Table 67. Tumour-cell Vaccine Customer List
Table 68. Global Tumour-cell Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Tumour-cell Vaccine Consumption Market Forecast by Region
Table 70. Global Tumour-cell Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Tumour-cell Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Tumour-cell Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Tumour-cell Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Tumour-cell Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Tumour-cell Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Tumour-cell Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Tumour-cell Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Tumour-cell Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Tumour-cell Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Tumour-cell Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Tumour-cell Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Tumour-cell Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Tumour-cell Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Tumour-cell Vaccine Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Tumour-cell Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Tumour-cell Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Tumour-cell Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 88. AVAX Technologies Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. AVAX Technologies Tumour-cell Vaccine Product Offered
Table 90. AVAX Technologies Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. AVAX Technologies Main Business
Table 92. AVAX Technologies Latest Developments
Table 93. Vaccinogen Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Vaccinogen Tumour-cell Vaccine Product Offered
Table 95. Vaccinogen Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Vaccinogen Main Business
Table 97. Vaccinogen Latest Developments
Table 98. Biovest Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Biovest Tumour-cell Vaccine Product Offered
Table 100. Biovest Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Biovest Main Business
Table 102. Biovest Latest Developments
Table 103. Aduro BioTech Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Aduro BioTech Tumour-cell Vaccine Product Offered
Table 105. Aduro BioTech Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. Aduro BioTech Main Business
Table 107. Aduro BioTech Latest Developments
Table 108. Regeneus Basic Information, Tumour-cell Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Regeneus Tumour-cell Vaccine Product Offered
Table 110. Regeneus Tumour-cell Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Regeneus Main Business
Table 112. Regeneus Latest Developments
List of Figures
Figure 1. Picture of Tumour-cell Vaccine
Figure 2. Tumour-cell Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumour-cell Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Tumour-cell Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Tumour-cell Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of MVax
Figure 10. Product Picture of OncoVAX
Figure 11. Product Picture of BiovaxID
Figure 12. Product Picture of Others
Figure 13. Global Tumour-cell Vaccine Sales Market Share by Type in 2020
Figure 14. Global Tumour-cell Vaccine Revenue Market Share by Type (2016-2021)
Figure 15. Tumour-cell Vaccine Consumed in Pediatrics
Figure 16. Global Tumour-cell Vaccine Market: Pediatrics (2016-2021) & (K Units)
Figure 17. Tumour-cell Vaccine Consumed in Adults
Figure 18. Global Tumour-cell Vaccine Market: Adults (2016-2021) & (K Units)
Figure 19. Global Tumour-cell Vaccine Sales Market Share by Application (2016-2021)
Figure 20. Global Tumour-cell Vaccine Revenue Market Share by Application in 2020
Figure 21. Tumour-cell Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Tumour-cell Vaccine Revenue Market Share by Company in 2020
Figure 23. Global Tumour-cell Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global Tumour-cell Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas Tumour-cell Vaccine Sales 2016-2021 (K Units)
Figure 26. Americas Tumour-cell Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC Tumour-cell Vaccine Sales 2016-2021 (K Units)
Figure 28. APAC Tumour-cell Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe Tumour-cell Vaccine Sales 2016-2021 (K Units)
Figure 30. Europe Tumour-cell Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Tumour-cell Vaccine Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Tumour-cell Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas Tumour-cell Vaccine Sales Market Share by Country in 2020
Figure 34. Americas Tumour-cell Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas Tumour-cell Vaccine Sales Market Share by Type in 2020
Figure 36. Americas Tumour-cell Vaccine Sales Market Share by Application in 2020
Figure 37. United States Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Tumour-cell Vaccine Sales Market Share by Region in 2020
Figure 42. APAC Tumour-cell Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC Tumour-cell Vaccine Sales Market Share by Type in 2020
Figure 44. APAC Tumour-cell Vaccine Sales Market Share by Application in 2020
Figure 45. China Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Tumour-cell Vaccine Sales Market Share by Country in 2020
Figure 52. Europe Tumour-cell Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe Tumour-cell Vaccine Sales Market Share by Type in 2020
Figure 54. Europe Tumour-cell Vaccine Sales Market Share by Application in 2020
Figure 55. Germany Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Tumour-cell Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Tumour-cell Vaccine Sales Market Share by Application in 2020
Figure 64. Egypt Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Tumour-cell Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

※본 조사보고서 [세계의 종양 세포 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02666) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 종양 세포 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년
LPI-2201K02170 / LP Information / 2021년 12월 / 본 조사보고서는 SARS-Cov-2 백신 (베로셀)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of SARS-Cov-2 Vaccine (Vero Cell) will have significant change from previous year. By the most conservative estimates of global SARS-Cov-2 Vaccine (Vero Cell) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 비강 스프레이 인플루엔자 백신 시장예측 2021년-2026년
LPI-2201K02102 / LP Information / 2021년 12월 / 본 조사보고서는 비강 스프레이 인플루엔자 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Nasal Spray Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Nasal Spray Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 폐렴구균 백신 시장예측 2021년-2026년
LPI-2201K02154 / LP Information / 2021년 12월 / 본 조사보고서는 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pneumococcal Bacteria Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Bacteria Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 수두 백신 시장예측 2021년-2026년
LPI-2201K02212 / LP Information / 2021년 12월 / 본 조사보고서는 수두 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Varicella Vaccine will have significant change from previous year. By the most conservative estimates of global Varicella Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3787.8 million in 2020. Over...

세계의 수막구균 백신 시장예측 2021년-2026년
LPI-2201K02087 / LP Information / 2021년 12월 / 본 조사보고서는 수막구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Meningococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Meningococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 245.5 million in 2020. Over...

세계의 백신 투여 시장예측 2021년-2026년
LPI-2201K02327 / LP Information / 2021년 12월 / 본 조사보고서는 백신 투여의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Vaccine Administration will have significant change from previous year. By the most conservative estimates of global Vaccine Administration market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...